Supplementary Figures
. a) Selected regions of 1 H-15 N HSQC spectra of 2N4R Tau (20 µM) in the absence (blue) and presence of tubulin (red). Tau:tubulin heterodimer ratio was 1:2. Spectra were recorded at 700 MHz 1 H frequency, 5 °C. Attenuated resonances other than those of TauR' (e.g. that of Y310) arise from the interaction of the proline--rich and repeat regions of Tau. b) Amino acid sequence of TauR'. c) Residue--specific attenuation of 1 H--15 N cross--peaks within the TauR' region upon addition of soluble tubulin to 2N4R Tau (Tau:tubulin ratio of 1:2). S3 Figure  S2 . 1 
Supplementary Experimental Section
STD NMR spectra [2] of TauR' and I19L with and without tubulin heterodimers were recorded on a 700 MHz spectrometer at 25 °C on samples containing 0.6 mM peptide and 15 μM tubulin (molar ratio 40:1). The magnetization of tubulin was saturated using a series of equally spaced 50 ms Gaussian--shaped pulses (40 pulses give a total saturation time of 1.5 s). On--and off-resonance frequencies were set to --0.5 ppm and 60 ppm, respectively. STD buildup curves were obtained with saturation times of 0.5, 1, 1.5, 2, 3, 4, 5 and 7 s. STD amplification factors (STD--AF) were calculated as the product of ηSTD (ratio of STD intensity to reference intensity) and the excess of ligand. [2] STD--AFs at different saturation times (t sat ) were fitted to the equation STD--AF(t sat ) = STD max (1-exp(−k sat t sat )), where STD max represents the asymptotic maximum of the STD buildup curve and k sat is a rate constant, which measures the speed of STD buildup. Binding affinities were determined using STD experiments at increasing peptide concentrations (TauR' and I19L) for constant tubulin concentrations of 10 μM and 5 μM, respectively. STD--AF values (at a fixed saturation time) of a peptide proton as a function of peptide concentration follows a hyperbolic dose--response curve [3] and were fitted according to STD--AF=(α STD * [L])/(K d +[L]), where α STD represents the maximum STD amplification factor for a given proton signal. INPHARMA experiments [4] were performed by acquiring 1 H-- 1 
